GNPX GNPX
Company Profile ↓Company Overview
GNPX (GNPX) is a publicly traded company listed on with a market capitalization of $664.28K. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -98.35% |
| 6 Months: | -91.59% |
| 3 Months: | -77.20% |
| 1 Month: | -65.85% |
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)24.67 · Oversold
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 99.5% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
- RSI at 25 suggests oversold conditions.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.97M | 4.68M | 3.35M | 3.52M | 4.49M |
| Operating Income | -719.86K | -751.30K | -1.18M | -715.12K | -686.63K | -6.04M | -2.20M | -2.17M | -3.70M | -2.38M | -5.58M | -4.38M | -2.78M | -5.31M | -3.99M | -3.44M | -5.31M | -5.77M | -6.17M | -9.26M | -8.04M | -7.79M | -6.00M | -6.52M | -4.32M | - | -3.97M | -4.68M | -3.35M | -3.52M | -4.49M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.97M | -4.68M | -3.34M | -3.51M | -4.49M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 455.55K | 284.39K | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.96M | -4.67M | -3.80M | -3.79M | -4.46M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | -719.86K | -751.30K | -1.18M | -715.10K | -694.00K | -6.06M | -2.19M | -2.16M | -3.70M | -2.38M | -5.57M | -4.37M | -2.77M | -5.31M | -3.99M | -3.44M | -5.31M | -5.76M | -6.14M | -9.20M | -7.98M | -7.75M | -5.97M | -6.50M | -4.32M | - | -3.96M | -4.67M | -3.80M | -3.79M | -4.46M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -285.56 | -187.00 | -110.00 | - | -14.08 |
| R&D Expense | 89.90K | 68.36K | 104.98K | 55.52K | 51.62K | 112.97K | 489.69K | 508.04K | 502.04K | 467.34K | 1.48M | 2.16M | 1.35M | 2.04M | 1.53M | 1.43M | 2.04M | 2.93M | 3.16M | 5.31M | 3.98M | 4.62M | 3.27M | 1.67M | 2.76M | - | 2.54M | 2.50M | 2.19M | - | 2.75M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | - |
| Operating Income | -4.13M | -3.31M | -12.36M | -10.68M | -17.96M | -20.67M | -23.83M | -31.06M | -21.17M | -15.52M |
| Net Income | -4.13M | -3.31M | -12.37M | -10.65M | -17.94M | -20.66M | -23.74M | -30.86M | -21.11M | -16.23M |
| R&D Expense | 354.88K | 289.93K | 971.43K | 1.97M | 7.30M | 8.97M | 11.51M | 17.62M | 10.54M | 9.43M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 1.91M | 1.26M | 9.27M | 3.53M | 31.37M | - | 39.41M | 34.57M | 29.95M | 25.09M | 10.67M | 4.12M | 10.16M |
| Current Assets | - | - | - | - | - | - | - | - | - | - | 21.47M | 7.53M | 2.08M | 8.36M |
| Cash & Equivalents | 234.22K | 1.60M | 161.25K | - | - | - | - | - | - | - | 20.95M | 6.74M | 1.60M | 7.83M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | 0 | - | - | - | 34.85K | 0 | - | - |
| Total Liabilities | - | - | - | - | - | - | - | 2.38M | 2.15M | 2.46M | 2.81M | 3.25M | 2.50M | 2.20M |
| Current Liabilities | - | 285.66K | 830.96K | 387.82K | 510.68K | 450.72K | - | - | - | - | 2.81M | 3.25M | 2.50M | 2.17M |
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 393.74K | 1.62M | 428.57K | 8.88M | 3.02M | 30.92M | - | 37.02M | 32.41M | 27.49M | 22.27M | 7.42M | 1.62M | 7.96M |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | 1.09K | 1.35K | 9.87K | 149.61K |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.25M | -2.17M | -6.85M | -6.92M | -13.94M | -14.28M | -17.62M | -24.74M | -17.92M | -15.31M |
| Investing Cash Flow | -89.53K | -63.42K | -103.32K | -946.90K | -2.34M | -83.80K | -59.73K | -71.21K | 774.64K | 0 |
| Financing Cash Flow | 2.71M | 793.97K | 15.39M | 1.27M | 41.59M | 25.68M | 6.43K | 10.59M | 12.01M | 21.54M |
| Capital Expenditure | -4.98K | -5.89K | -22.43K | -33.37K | -17.56K | -31.70K | -0 | - | - | - |
| Free Cash Flow | -1.25M | -2.18M | -6.87M | -6.95M | -13.95M | -14.32M | -17.62M | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - |
| Net Margin % | - | - | - | - | - | - | - | - | - | - |
| ROE % | -254.3% | -773.3% | -139.3% | -352.4% | -58.0% | - | -106.6% | -416.1% | -1,303.0% | -203.8% |
| ROCE % | -254.3% | -772.9% | -139.2% | -353.3% | -58.1% | - | -107.0% | -418.8% | -1,306.9% | -194.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for GNPX
GNPX Stock Draws Trader Focus After Wild Price Swing - StocksToTrade
<a href="https://news.google.com/rss/articles/CBMickFVX3lxTE82UGhBdTNWbWZLcUlJUUdRc21OMDRGa0w0cUVST25KN3ozbnJDNFJHMFdMZGk4MHRlbnBFQzNEMkp2NF9mQlM3djVDZHBJdHBCRDN5QmowX2dSSHNlZ0JTdTdjS2l3NGhPVFB2a3RmQW9YQQ?oc=5" target="_blank">GNPX Stock Dr…
Genprex Data Correlate TROP2, PTEN Scores With Longer Time Without Progression - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxQY2ppMGxNa3ZRempLcjZWQ3lWcTNzS1hnN01IM0VfdVZZYU1PQ3BoZFJlQlpHdm1DeDJWcWRKOElFYl9obHRqOG9NSVZvRG1Id3A1Y0h6M3Z5VGlXemx0dG9vN3RNc3FXb3Z5VWt4WHJTeVZmV0pKZmJLdmFXRGhwSWxUa3ZiREt2M0RJbT…
GNPX Stock Slides As Volatility Grips Genprex Inc. - timothysykes.com
<a href="https://news.google.com/rss/articles/CBMieEFVX3lxTE9WNzlZYlp5eUVqUnNFVGRFNERhdTNGajhTb2gzVTBuVjMzUlFEOERqeUU1bDd2eHkyY0hwdHIxRlpLM3FqVEFzN3VYNHNzYUN4MnJ4dDU1MXZmc2ZHWkpXYzIxUWhZTHBvMXo1NU0wT01FTjZCTzJ5Yg?oc=5" target="_blank">GNPX …
Genprex stock rises on Roche Diagnostics collaboration - Investing.com
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxOeU9tWm1ISHNtSnNCVDZIVWtLUUVTWV94VmNnclVmR2FDLTlpelNqWXpyLTE4THRVWDNGZkJqSzRDWjBDYlctWHoydE0yVlFQVkpocW8wZzVCNzFZZXVKNE5qQkdHYW1ySlM1TWZRdkNvcGJmTUxIdDZXcktuTl90WnNoQ1dNTXFVX2dXUD…
$GNPX stock is up 8% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxOQ3ZCSEx0Y1NJODVfdUNWT3JIR2NfX3ZNQUR6SjZ1N1RseUZLUDdBdkZJV2oyQXk3b2N5TnRtb09TQzYyaUtKM0hMbGlKNWFrVnVoUE96ZmM1U3ZacktMTUFsTW5veVhnQk9lNTlKNzVCTWhZMEx0S0t0MFQ2YW9JOUVmakJMamhuN3FEY2…
Genprex Granted Nasdaq Listing Exception Amid Compliance Push - theglobeandmail.com
<a href="https://news.google.com/rss/articles/CBMi4gFBVV95cUxPRGJ6aTY5OGFSVHZ3cTlwcS1vQklpRGo4ZUJWWTg0M1JaaTBzaTlrR3QtRDhoM0l2M2dyM1dnTG00cDYtMU8zVWFJVm5FLWg1WVhsMHUyUm1FdTgzaHpFa0RzdDMybUdJYmpNSE1XRUF3T28xc0hXTWVpUmRlOE1PcDFzV1B4dGMydnV5U2…
GNPX — Frequently Asked Questions
What is the current share price of GNPX?
As of 2026-08-05 17:25 PDT, GNPX trades at $4.44 on NASDAQ/NYSE. Its 52-week range is $4.42 to $924.00.
What is the market capitalisation of GNPX?
GNPX has a market capitalisation of $664.28K on NASDAQ/NYSE.
Is GNPX a good stock to buy?
This page provides a data-driven analysis of GNPX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.